{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:09:15Z","timestamp":1790989755339,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-024-10103-9","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T15:09:20Z","timestamp":1733411360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Value of miR200b and its combination with other biochemical markers in the diagnosis of epithelial ovarian cancer"],"prefix":"10.1007","volume":"52","author":[{"given":"Doaa","family":"Helmy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Mossallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"issue":"6","key":"10103_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.936","volume":"5","author":"A Mazidimoradi","year":"2022","unstructured":"Mazidimoradi A, Momenimovahed Z, Allahqoli L, Tiznobaik A, Hajinasab N, Salehiniya H, Alkatout I (2022) The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer. Health Sci Rep 5(6):e936. https:\/\/doi.org\/10.1002\/hsr2.936","journal-title":"Health Sci Rep"},{"key":"10103_CR2","unstructured":"Arora T, Mullangi S, Vadakekut ES, Lekkala MR (2024) Epithelial ovarian cancer. [Updated 2024 May 6]. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island"},{"key":"10103_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/biomedicines10010077","volume":"10","author":"MP Garrido","year":"2022","unstructured":"Garrido MP, Fredes AN, Lobos-Gonz\u00e1lez L, Valenzuela-Valderrama M, Vera DB, Romero C (2022) Current treatments and new possible complementary therapies for epithelial ovarian cancer. Biomedicines 10:77\u2013108. https:\/\/doi.org\/10.3390\/biomedicines10010077","journal-title":"Biomedicines"},{"issue":"3","key":"10103_CR4","doi-asserted-by":"publisher","first-page":"682","DOI":"10.5114\/aoms\/110672","volume":"18","author":"M Nowak","year":"2021","unstructured":"Nowak M, Janas \u0141, Soja M, G\u0142owacka E, Szy\u0142\u0142o K, Misiek M, Klink M (2021) Chemokine expression in patients with ovarian cancer or benign ovarian tumors. Arch Med Sci 18(3):682\u2013689. https:\/\/doi.org\/10.5114\/aoms\/110672","journal-title":"Arch Med Sci"},{"issue":"3","key":"10103_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3390\/diagnostics11030465","volume":"11","author":"GA Atallah","year":"2021","unstructured":"Atallah GA, Abd Aziz NH, Teik CK, Shafiee MN, Kampan NC (2021) New predictive biomarkers for ovarian cancer. Diagnostics (Basel, Switzerland) 11(3):465\u2013485. https:\/\/doi.org\/10.3390\/diagnostics11030465","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"10103_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13048-020-00643-6","volume":"13","author":"A Hada","year":"2020","unstructured":"Hada A, Han L, Chen Y, Hu Q, Yuan Y, Liu L (2020) Comparison of the predictive performance of risk of malignancy indexes 1\u20134, HE4 and risk of malignancy algorithm in the triage of adnexal masses. J Ovarian Res 13:46\u201355","journal-title":"J Ovarian Res"},{"issue":"9","key":"10103_CR7","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1515\/cclm-2018-1111","volume":"57","author":"S Ferraro","year":"2019","unstructured":"Ferraro S, Panteghini M (2019) Making new biomarkers a reality: the case of serum human epididymis protein 4. Clin Chem Lab Med 57(9):1284\u20131294. https:\/\/doi.org\/10.1515\/cclm-2018-1111","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"10103_CR8","first-page":"1440","volume":"11","author":"CJ Dunton","year":"2021","unstructured":"Dunton CJ, Hutchcraft ML, Bullock RG, Northrop LE, Ueland FR (2021) Salvaging detection of early-stage ovarian malignancies when CA125 s not informative. Diagnostics (Basel Switzerland) 11(8):1440\u20131148","journal-title":"Diagnostics (Basel Switzerland)"},{"issue":"28","key":"10103_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015336","volume":"98","author":"C Kumarasamy","year":"2019","unstructured":"Kumarasamy C, Madhav MR, Sabarimurugan S, Lakhotiya K, Pandey V, Priyadharshini T, Baxi S, Gothandam KM, Jayaraj R (2019) Diagnostic and prognostic role of HE4 expression in multiple carcinomas: a protocol for systematic review and meta-analysis. Medicine 98(28):e15336. https:\/\/doi.org\/10.1097\/MD.0000000000015336","journal-title":"Medicine"},{"issue":"11","key":"10103_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225249","volume":"14","author":"DNP Oliveira","year":"2019","unstructured":"Oliveira DNP, Carlsen AL, Heegaard NHH, Prahm KP, Christensen IJ, H\u00f8gdall CK, H\u00f8gdall EV (2019) Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass. PLoS ONE 14(11):e0225249. https:\/\/doi.org\/10.1371\/journal.pone.0225249","journal-title":"PLoS ONE"},{"issue":"1","key":"10103_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12672-023-00674-7","volume":"14","author":"J Xiong","year":"2023","unstructured":"Xiong J, Fu F, Yu F, He X (2023) Advances of exosomal miRNAs in the diagnosis and treatment of ovarian cancer. Discov Oncol 14(1):65\u201375. https:\/\/doi.org\/10.1007\/s12672-023-00674-7","journal-title":"Discov Oncol"},{"key":"10103_CR12","doi-asserted-by":"publisher","first-page":"20071","DOI":"10.1038\/s41598-020-77068-0","volume":"10","author":"PW Choi","year":"2020","unstructured":"Choi PW, Bahrampour A, Ng SK, Liu SK, Qiu W, Xie F et al (2020) Characterization of mir-200 family members as blood biomarkers for human and laying hen ovarian cancer. Sci Rep 10:20071\u201320078. https:\/\/doi.org\/10.1038\/s41598-020-77068-0","journal-title":"Sci Rep"},{"issue":"13","key":"10103_CR13","doi-asserted-by":"publisher","first-page":"16923","DOI":"10.18632\/oncotarget.7850","volume":"7","author":"X Meng","year":"2016","unstructured":"Meng X, M\u00fcller V, Milde-Langosch K, Trillsch F, Pantel K, Schwarzenbach H (2016) Diagnostic and prognostic relevance of circulating exosomal Mir-373, mir-200a, mir-200b and mir-200c in patients with epithelial ovarian cancer. Oncotarget 7(13):16923\u201316935. https:\/\/doi.org\/10.18632\/oncotarget.7850","journal-title":"Oncotarget"},{"issue":"10","key":"10103_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s12094-015-1303-1","volume":"17","author":"M Zuberi","year":"2015","unstructured":"Zuberi M, Mir R, Das J, Ahmad I, Javid J, Yadav P et al (2015) Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features. Clin Transl Oncol 17(10):779\u2013787. https:\/\/doi.org\/10.1007\/s12094-015-1303-1","journal-title":"Clin Transl Oncol"},{"key":"10103_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s13104-020-05155-6","volume":"13","author":"K Savolainen","year":"2020","unstructured":"Savolainen K, Scaravilli M, Ilvesm\u00e4ki A, Staff S, Tolonen T, M\u00e4enp\u00e4\u00e4 J et al (2020) Expression of the mir-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts. BMC Res Notes 13:313\u2013320. https:\/\/doi.org\/10.1186\/s13104-020-05155-6","journal-title":"BMC Res Notes"},{"issue":"19","key":"10103_CR16","doi-asserted-by":"publisher","first-page":"12041","DOI":"10.3390\/ijms231912041","volume":"23","author":"R Zhang","year":"2022","unstructured":"Zhang R, Siu MKY, Ngan HYS, Chan KKL (2022) Molecular biomarkers for the early detection of ovarian cancer. Int J Mol Sci 23(19):12041. https:\/\/doi.org\/10.3390\/ijms231912041","journal-title":"Int J Mol Sci"},{"key":"10103_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3404059","author":"W Guan","year":"2020","unstructured":"Guan W, Cui H, Huang P, Chun WJ, Lee J-W, Kim H, Zou H (2020) Mir-200B\/200A\/429 cluster stimulates ovarian cancer development by targeting ING5. J Oncol. https:\/\/doi.org\/10.1155\/2020\/3404059","journal-title":"J Oncol"},{"issue":"7","key":"10103_CR18","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.21037\/tcr-22-864","volume":"11","author":"L Liu","year":"2022","unstructured":"Liu L, Li P, Wang Q, Dong C, Guo M, Wang R (2022) Diagnosis accuracy of the miR-200 family tumor marker series in ovarian cancer: a systematic review and meta-analysis. Transl Cancer Res 11(7):2283\u20132290. https:\/\/doi.org\/10.21037\/tcr-22-864","journal-title":"Transl Cancer Res"},{"key":"10103_CR19","doi-asserted-by":"publisher","first-page":"1075942","DOI":"10.1155\/2020\/1075942","volume":"2020","author":"Y Cui","year":"2020","unstructured":"Cui Y, Hong S, Zhu X (2020) The accuracy of single microRNAs in peripheral blood to diagnose ovarian cancer: an updated meta-analysis. Dis Markers 2020:1075942. https:\/\/doi.org\/10.1155\/2020\/1075942","journal-title":"Dis Markers"},{"issue":"4","key":"10103_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1158\/1940-6207.CAPR-23-0156","volume":"17","author":"S Alimena","year":"2024","unstructured":"Alimena S, Stephenson BJK, Webber JW, Wollborn L, Sussman CB, Packard DG, Williams M, Comrie CE, Wang JY, Markert T, Spiegel J, Rodriguez CB, Lightfoot M, Graye A, O\u2019Connor S, Elias KM (2024) Differences in serum miRNA profiles by race, ethnicity, and socioeconomic status: implications for developing an equitable ovarian cancer screening test. Cancer Prev Res 17(4):177\u2013185. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-23-0156","journal-title":"Cancer Prev Res"},{"issue":"2","key":"10103_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/bib\/bbv056","volume":"17","author":"F Marabita","year":"2016","unstructured":"Marabita F, de Candia P, Torri A, Tegn\u00e9r J, Abrignani S, Rossi RL (2016) Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR. Brief Bioinform 17(2):204\u2013212. https:\/\/doi.org\/10.1093\/bib\/bbv056","journal-title":"Brief Bioinform"},{"issue":"Pt 2","key":"10103_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.131926","volume":"269","author":"T Belmonte","year":"2024","unstructured":"Belmonte T, Perez-Pons M, Ben\u00edtez ID, Molinero M, Garc\u00eda-Hidalgo MC, Rodr\u00edguez-Mu\u00f1oz C, Gort-Paniello C, Moncus\u00ed-Moix A, Mad\u00e8 A, Devaux Y, Martelli F, Ortega A, Gonz\u00e1lez J, Torres G, Barb\u00e9 F, de Gonzalo-Calvo D (2024) Addressing the unsolved challenges in microRNA-based biomarker development: suitable endogenous reference microRNAs for SARS-CoV-2 infection severity. Int J Biol Macromol 269(Pt 2):131926. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131926","journal-title":"Int J Biol Macromol"},{"key":"10103_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-021-00826-9","author":"J Xiong","year":"2021","unstructured":"Xiong J, He X, Xu Y, Zhang W, Fu F (2021) MiR-200b is upregulated in plasma-derived exosomes and functions as an oncogene by promoting macrophage M2 polarization in ovarian cancer. J Ovarian Res. https:\/\/doi.org\/10.1186\/s13048-021-00826-9","journal-title":"J Ovarian Res"},{"issue":"5","key":"10103_CR24","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1007\/s10528-023-10356-2","volume":"61","author":"V Shukla","year":"2023","unstructured":"Shukla V, Mallya S, Adiga D, Sriharikrishnaa S, Chakrabarty S, Kabekkodu SP (2023) Bioinformatic analysis of miR-200b\/429 and hub gene network in cervical cancer. Biochem Genet 61(5):1898\u20131916. https:\/\/doi.org\/10.1007\/s10528-023-10356-2","journal-title":"Biochem Genet"},{"key":"10103_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s43168-020-00021-2","author":"SA Mansour","year":"2020","unstructured":"Mansour SA, Farhat AA, Abd El-Zaher AH, Bedewy AS, Abdou SM, Alska AA, Zidan AA (2020) MicroRNA genetic signature in non-small cell lung cancer (NSCLC) Egyptian patients. Egypt J Bronchol. https:\/\/doi.org\/10.1186\/s43168-020-00021-2","journal-title":"Egypt J Bronchol"},{"key":"10103_CR26","doi-asserted-by":"publisher","first-page":"153303381989259","DOI":"10.1177\/1533033819892590","volume":"18","author":"K Liu","year":"2019","unstructured":"Liu K, Zhang W, Tan J, Ma J, Zhao J (2019) MiR-200b-3p functions as an oncogene by targeting ABCA1 in lung adenocarcinoma. Technol Cancer Res Treat 18:1533033819892590. https:\/\/doi.org\/10.1177\/1533033819892590","journal-title":"Technol Cancer Res Treat"},{"issue":"3","key":"10103_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00404-022-06442-2","volume":"306","author":"C Fischer","year":"2022","unstructured":"Fischer C, Deutsch TM, Feisst M, Rippinger N, Riedel F, Hartkopf AD, Brucker SY, Domschke C, Fremd C, Michel L, Burwinkel B, Schneeweiss A, Turchinovich A, Wallwiener M (2022) Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer. Arch Gynecol Obstet 306(3):875\u2013885. https:\/\/doi.org\/10.1007\/s00404-022-06442-2","journal-title":"Arch Gynecol Obstet"},{"issue":"9","key":"10103_CR28","doi-asserted-by":"publisher","first-page":"966","DOI":"10.18632\/oncotarget.26629","volume":"10","author":"C Papadaki","year":"2019","unstructured":"Papadaki C, Stoupis G, Tsalikis L, Monastirioti A, Papadaki M, Maliotis N, Stratigos M, Mastrostamatis G, Mavroudis D, Agelaki S (2019) Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer. Oncotarget 10(9):966\u2013981. https:\/\/doi.org\/10.18632\/oncotarget.26629","journal-title":"Oncotarget"},{"issue":"5","key":"10103_CR29","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3892\/ol.2021.13066","volume":"22","author":"V Gurbuz","year":"2021","unstructured":"Gurbuz V, Sozen S, Bilen CY, Konac E (2021) miR-148a, miR-152 and miR-200b promote prostate cancer metastasis by targeting DNMT1 and PTEN expression. Oncol Lett 22(5):805. https:\/\/doi.org\/10.3892\/ol.2021.13066","journal-title":"Oncol Lett"},{"issue":"5","key":"10103_CR30","doi-asserted-by":"publisher","first-page":"933","DOI":"10.32604\/or.2023.042581","volume":"32","author":"X Wang","year":"2024","unstructured":"Wang X, Jia Y, Li Q, Yang Q, Liu Y, Wei B, Niu X, Zhang Y, Luo X, Zhao Z, Wang P (2024) miR-200b-3p accelerates progression of pituitary adenomas by negatively regulating expression of RECK. Oncol Res 32(5):933\u2013941. https:\/\/doi.org\/10.32604\/or.2023.042581","journal-title":"Oncol Res"},{"key":"10103_CR31","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fgene.2020.00418","volume":"11","author":"L Guo","year":"2020","unstructured":"Guo L, Yang G, Kang Y, Li S, Duan R, Shen L, Jiang W, Qian B, Yin Z, Liang T (2020) Construction and analysis of a ceRNA network reveals potential prognostic markers in colorectal cancer. Front Genet 11:418. https:\/\/doi.org\/10.3389\/fgene.2020.00418","journal-title":"Front Genet"},{"issue":"11","key":"10103_CR32","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1007\/s00784-020-03608-7","volume":"24","author":"S Patil","year":"2020","unstructured":"Patil S, Warnakulasuriya S (2020) Blood-based circulating microRNAs as potential biomarkers for predicting the prognosis of head and neck cancer-a systematic review. Clin Oral Invest 24(11):3833\u20133841. https:\/\/doi.org\/10.1007\/s00784-020-03608-7","journal-title":"Clin Oral Invest"},{"issue":"20","key":"10103_CR33","first-page":"4536","volume":"21","author":"QP Xi","year":"2017","unstructured":"Xi QP, Pu DH, Lu WN (2017) Research on application value of combined detection of serum CA125, HE4 and TK1 in the diagnosis of ovarian cancer. Eur Rev Med Pharmacol Sci 21(20):4536\u20134541","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10103_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ygyno.2018.08.025","volume":"151","author":"M Lycke","year":"2018","unstructured":"Lycke M, Kristjansdottir B, Sundfeldt K (2018) A multicenter clinical trial validating the performance of HE4, CA125, risk of ovarian malignancy algorithm and risk of malignancy index. Gynecol Oncol 151(1):159\u2013165. https:\/\/doi.org\/10.1016\/j.ygyno.2018.08.025","journal-title":"Gynecol Oncol"},{"key":"10103_CR35","doi-asserted-by":"publisher","first-page":"175883592412332","DOI":"10.1177\/17588359241233225","volume":"16","author":"A Ghose","year":"2024","unstructured":"Ghose A, McCann L, Makker S, Mukherjee U, Gullapalli SVN, Erekkath J, Shih S, Mahajan I, Sanchez E, Uccello M, Moschetta M, Adeleke S, Boussios S (2024) Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4. Ther Adv Med Oncol 16:17588359241233224. https:\/\/doi.org\/10.1177\/17588359241233225","journal-title":"Ther Adv Med Oncol"},{"key":"10103_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.595835","volume":"11","author":"PC Hart","year":"2020","unstructured":"Hart PC, Rajab IM, Alebraheem M, Potempa LA (2020) C-Reactive protein and cancer-diagnostic and therapeutic insights. Front Immunol 11:595835. https:\/\/doi.org\/10.3389\/fimmu.2020.595835","journal-title":"Front Immunol"},{"issue":"6","key":"10103_CR37","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.7150\/jca.50733","volume":"12","author":"W Wang","year":"2021","unstructured":"Wang W, Xie H, Xia B, Zhang L, Hou Y, Li K (2021) Identifying potential markers for monitoring progression to ovarian cancer using plasma label-free proteomics. J Cancer 12(6):1651\u20131659. https:\/\/doi.org\/10.7150\/jca.50733","journal-title":"J Cancer"},{"issue":"1","key":"10103_CR38","doi-asserted-by":"publisher","first-page":"20056","DOI":"10.1038\/s41598-020-77167-y","volume":"10","author":"D Yang","year":"2020","unstructured":"Yang D, Li H, Sun X, Yang S, Wang K, Liu Z (2020) Clinical usefulness of high levels of C-reactive protein for diagnosing epithelial ovarian cancer. Sci Rep 10(1):20056\u201320063. https:\/\/doi.org\/10.1038\/s41598-020-77167-y","journal-title":"Sci Rep"},{"issue":"1","key":"10103_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5301\/jbm.5000226","volume":"32","author":"A Yoshida","year":"2017","unstructured":"Yoshida A, Derchain SF, Pitta DR, Crozatti N, Andrade LALA, da Silva RF, Sarian LO (2017) Preoperative measurement of serum C-reactive protein: is it useful in the differential diagnosis of adnexal masses? Int J Biol Markers 32(1):83\u201389. https:\/\/doi.org\/10.5301\/jbm.5000226","journal-title":"Int J Biol Markers"},{"issue":"12","key":"10103_CR40","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.18632\/oncotarget.27246","volume":"11","author":"P Ferreira","year":"2020","unstructured":"Ferreira P, Roela RA, Lopez RVM, Del Pilar Estevez-Diz M (2020) The prognostic role of microRNA in epithelial ovarian cancer: a systematic review of literature with an overall survival meta-analysis. Oncotarget 11(12):1085\u20131095. https:\/\/doi.org\/10.18632\/oncotarget.27246","journal-title":"Oncotarget"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-10103-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-10103-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-10103-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:27:46Z","timestamp":1766852866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-10103-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10103"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-10103-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the institutional review board (IRB), National Cancer Institute, Cairo University. Organization No. IORG0003381, IRB No. IRB00004025.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"An informed consent was obtained from all the subjects prior to their enrolment in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"35"}}